Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
24.8 USD | +0.08% | -4.28% | -15.99% |
10/05 | Morgan Stanley Adjusts Price Target on Mirum Pharmaceuticals to $53 From $57, Keeps Overweight Rating | MT |
08/05 | Transcript : Mirum Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 08, 2024 |